Atlas Trials

Recurrent WHO Grade III Glioma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent WHO Grade III Glioma

RecordFirmDate
Combination Therapy for the Treatment of Diffuse Midline Gliomas (NCT05009992)University of California, San Francisco2021-10-20
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma (NCT04214392)City of Hope Medical Center2020-02-26
BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations (NCT03914742)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2020-02-16
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (NCT03749187)University of California, San Francisco2019-04-03
Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms (NCT04044937)Thomas Hope2018-10-29
Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma (NCT04540107)Susan Chang2017-01-11
Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas (NCT02192359)City of Hope Medical Center2016-04-05
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma (NCT02208362)City of Hope Medical Center2015-05-18

Track Recurrent WHO Grade III Glioma automatically

Every clearance here is in the API, with alerts when new ones post.